The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last ...

The update covers devices used in procedures to implant the company’s Watchman heart device.

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for durable medical equipment ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...

More than 60 companies, including Amazon, Google, UnitedHealth and Epic, have pledged to participate in the initiative, which ...

CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million ...

The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

CEO Christian Mazzi said the minimally invasive surgical technique could provide better outcomes for patients than ...